Urovant Sciences Competitors and Similar CompaniesClear all

Urovant Sciences's competitors and similar companies include Pfizer and Kymera Therapeutics.

	Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.	Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Founding Date	Founding Date 2016	Founding Date 1849	Founding Date 2017
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech drug development therapy
Locations	Locations Irvine, US HQ Basel, CH	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more	Locations Watertown, US HQ Cambridge, US
Employees	Employees 3950% increase	Employees 81,0008% decrease	Employees 207
Valuation ($)	Valuation ($) N/A	Valuation ($) 163.9 b	Valuation ($) 3.1 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $62.6b (FY, 2025)	Revenue (est.) $39.2m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $16.1b (FY, 2025)	Cost of goods $39.2m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $46.5b (FY, 2025)	Gross profit N/A
Net income	Net income ($146.7m) (FY, 2020)	Net income $7.8b (FY, 2025)	Net income ($311.4m) (FY, 2025)